No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.

Autor: Jelle Evers, Anne J Grotenhuis, Katja K H Aben, Lambertus A L M Kiemeney, Alina Vrieling

Publikováno v: PLoS ONE, Vol 15, Iss 3, p e0229384 (2020)

BackgroundNon-muscle invasive bladder cancer patients are at high risk for tumour recurrence and progression, hence an intensive follow-up procedure is recommended which is costly. Identification of factors that are associated with the risk of recurr

Externí odkaz: https://doaj.org/article/106206717fa84e2dacb2215e56147f11

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer

Autor: Núria Malats, Richard T. Bryan, Philippe Lamy, Lambertus A. Kiemeney, Tessel E. Galesloot, Kar Keung Cheng, Dimitar Kolev, Sita H. Vermeulen, Neil Fleshner, Anne J. Grotenhuis, Lourdes Mengual, Katja K.H. Aben, Nicholas D. James, Samantha Conroy, Maurice P. Zeegers, Gerald W. Verhaegh, James W.F. Catto, Sia Viborg Lindskrog, Lars Dyrskjøt

Publikováno v: European Urology Oncology, 5, 1, pp. 70-83
European Urology Oncology, 5, 70-83
Galesloot, T E, Grotenhuis, A J, Kolev, D, Aben, K K, Bryan, R T, Catto, J W F, Cheng, K K, Conroy, S, Dyrskjøt, L, Fleshner, N E, James, N D, Lamy, P, Lindskrog, S V, Malats, N, Mengual, L, Verhaegh, G, Zeegers, M P, Kiemeney, L A L M & Vermeulen, S H 2022, ' Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer ', European urology oncology, vol. 5, no. 1, pp. 70-83 . https://doi.org/10.1016/j.euo.2021.07.001
European Urology Oncology, 5(1), 70-83. Elsevier

Background: Non-muscle-invasive bladder cancer (NMIBC) is characterized by frequent recurrences and a risk of progression in stage and grade. Increased knowledge of underlying biological mechanisms is needed.Objective: To identify single nucleotide p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133e90041097f359b905086fa42b67ef
https://repository.ubn.ru.nl/handle/2066/248271

Prognostic relevance of urinary bladder cancer susceptibility loci.

Autor: Anne J Grotenhuis, Aleksandra M Dudek, Gerald W Verhaegh, J Alfred Witjes, Katja K Aben, Saskia L van der Marel, Sita H Vermeulen, Lambertus A Kiemeney

Publikováno v: PLoS ONE, Vol 9, Iss 2, p e89164 (2014)

In the last few years, susceptibility loci have been identified for urinary bladder cancer (UBC) through candidate-gene and genome-wide association studies. Prognostic relevance of most of these loci is yet unknown. In this study, we used data of the

Externí odkaz: https://doaj.org/article/ed9e22312aed4b26910fb7d7392251ac

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

Autor: Juan Palou, Shahrokh F. Shariat, Robert Jeffrey Karnes, R. Bartoletti, Núria Malats, Jack Baniel, J. Varkarakis, E.N. Xylinas, S. M. Di Stasi, Eugene K. Cha, Per-Uno Malmström, J. Irani, T. Tony Cai, Guido Dalbagni, S. Joniau, Paolo Gontero, Viktor Soukup, Stéphane Larré, Anne J. Grotenhuis, Alfred Witjes, Marek Babjuk, P. Ardelt, Roy Mano, Alberto Briganti, Richard Sylvester, Vincenzo Serretta, Renzo Colombo, B.W.G. Van Rhijn, Francesca Pisano

Publikováno v: World Journal of Urology, 36, 1621-1627
WORLD JOURNAL OF UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
World Journal of Urology, 36, 10, pp. 1621-1627
World J Urol

PURPOSE: The goals of transurethral resection of a bladder tumor (TUR) are to completely resect the lesions and to make a correct diagnosis to adequately stage and treat the patient. Persistent disease after TUR is not uncommon and is why re-TUR is r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8bdb962b4b8d6ba468b00f8ec0d68fb
http://hdl.handle.net/2066/195867

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

Autor: Paolo Gontero, Jennifer Irani, J. Varkarakis, S. M. Di Stasi, Guido Dalbagni, Eugene K. Cha, E.N. Xylinas, Viktor Soukup, Vincenzo Serretta, Renzo Colombo, T. Tony Cai, Núria Malats, S. Joniau, Anne J. Grotenhuis, Per-Uno Malmström, Roy Mano, S. Larrè, Marek Babjuk, Richard Sylvester, Alberto Briganti, R. Bartoletti, Jack Baniel, S.F. Shariat, Juan Palou, P. Ardelt, Francesca Pisano, J.A. Witjes, Robert Jeffrey Karnes, Francesco Soria, B.W.G. Van Rhijn

Publikováno v: Translational Andrology and Urology
World Journal of Urology, 36, 11, pp. 1775-1781
WORLD JOURNAL OF UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
World Journal of Urology, 36, 1775-1781

PURPOSE: To evaluate the oncological impact of postponing radical cystectomy (RC) to allow further conservative therapies prior to progression in a large multicentre retrospective cohort of T1-HG/G3 patients initially treated with BCG. METHODS: Accor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f027e8018edecafb45a19c2bf9ec8c23
http://hdl.handle.net/10447/359502